Skip to main content

Deze website is uitsluitend voorbehouden aan beroepsbeoefenaren in Nederland.

Aim of cGvHD treatment and general considerations

NCCN guidelines for the management of cGvHD3 

*central line access, IV infusion, injection, pill that is convenient for patients.

BD, twice daily; cGvHD, chronic-graft-versus host disease; CR, complete response; CS, corticosteroids; CNIs, calcineurin inhibitors; ECP, Electrocorproeal photopheresis; FFS, failure-free survival; MMF, Mycophenolic acid; NR, not registered; OD, once daily; ORR, overall response rate; PR, partial response; QoL, quality of life; SR, steroid refractory; SOC, standard of care; URTI, upper respiratory tract infection; NCCN, National Comprehensive Cancer Network; EBMT, European Society for Blood and Marrow Transplantation.

MAT-BE-2500625, v1.0, May 2025